Lung cancer, Lancet, vol.355, pp.479-85, 2000. ,
URL : https://hal.archives-ouvertes.fr/hal-01868690
Percutaneous radiofrequency ablation of malignancies in the lung, AJR, vol.174, pp.57-59, 2000. ,
Pathologic assessment of radiofrequency ablation of pulmonary metastases, JVIR, vol.21, pp.1689-1696, 2010. ,
Lung cancer ablation: technologies and techniques, Semin Interv Radiol, vol.30, pp.141-150, 2013. ,
The Role of Percutaneous ImageGuided Thermal Ablation for the Treatment of Pulmonary Malignancies, AJR, vol.209, pp.740-751, 2017. ,
Radiofrequency ablation of lung metastases: factors influencing success, Eur Radiol, vol.18, pp.672-667, 2008. ,
Expert consensus workshop report: Guidelines for thermal ablation of primary and metastatic lung tumors (2018 edition), J Cancer Res Ther, vol.14, pp.730-744, 2018. ,
ConeBeam Computed Tomography (CBCT) Versus CT in Lung Ablation Procedure: Which is Faster?, Cardiovasc Intervent Radiol, vol.38, pp.1231-1236, 2015. ,
Thermal ablation of tumours: biological mechanisms and advances in therapy, Nat Rev Cancer, vol.14, pp.199-208, 2014. ,
Radiofrequency ablation of lung tumors: imaging features of the postablation zone, Radiographics, vol.32, pp.947-969, 2012. ,
Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumors, Cardiovasc Intervent Radiol, vol.32, pp.478-483, 2009. ,
Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation--preliminary results, Radiology, vol.229, pp.821-829, 2003. ,
Radiofrequency ablation for eradication of pulmonary tumor in rabbits, J Surg Res, vol.99, pp.265-271, 2001. ,
Radiofrequency ablation of 40 lung neoplasms: preliminary results, AJR, vol.183, pp.361-368, 2004. ,
CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors, AJR, vol.185, p.40, 2005. ,
The Effect of Needle Gauge on the Risk of Pneumothorax and Chest Tube Placement After Percutaneous Computed Tomographic (CT)-Guided Lung Biopsy, Cardiovasc Intervent Radiol, vol.38, pp.1595-1602, 2015. ,
A systematic review of radiofrequency ablation for lung tumors, Ann Surg Oncol, vol.15, pp.1765-1774, 2008. ,
Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases, Ann Oncol, vol.26, pp.987-991, 2015. ,
Analysis of the factors associated with radiofrequency ablationinduced pneumothorax, Clin Radiol, vol.62, pp.639-644, 2007. ,
Complications after 1000 lung radiofrequency ablation sessions in 420 patients: a single center's experiences, AJR, vol.197, pp.576-580, 2011. ,
Delayed and recurrent pneumothorax after radiofrequency ablation of lung tumors, Chest, vol.135, pp.1002-1009, 2009. ,
Pulmonary hemorrhage during percutaneous radiofrequency ablation: a more frequent complication than assumed?, Interact Cardiovasc Thorac Surg, vol.2, pp.462-465, 2003. ,
Radiologic appearance and complications of percutaneous computed tomography-guided radiofrequency-ablated pulmonary metastases from colorectal carcinoma, J Comput Assist Tomogr, vol.27, pp.750-757, 2003. ,
Pulmonary artery pseudoaneurysm related to radiofrequency ablation of lung tumor, Cardiovasc Intervent Radiol, vol.33, pp.413-416, 2010. ,
Massive hemoptysis from pulmonary artery pseudoaneurysm caused by lung radiofrequency ablation: successful treatment by coil embolization, Cardiovasc Intervent Radiol, vol.33, pp.410-412, 2010. ,
Lung radiofrequency and microwave ablation: a review of indications, techniques and post-procedural imaging appearances, Br J Radiol, vol.88, 2015. ,
In vivo evaluation of lung microwave ablation in a porcine tumor mimic model, Cardiovasc Intervent Radiol, vol.36, pp.221-228, 2013. ,
Thermal Ablation of Colorectal Lung Metastases: Retrospective Comparison Among Laser-Induced Thermotherapy, Radiofrequency Ablation, and Microwave Ablation, AJR, vol.207, pp.1340-1349, 2016. ,
Cyberknife: A double edged sword?, Rep Pract 41 ,
, Oncol Radiother, vol.15, pp.93-97, 2010.
Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable nonsmall cell lung cancer?, Interact Cardiovasc Thorac Surg, vol.15, pp.258-265, 2012. ,
, Lung Cancer Ablation: Complications. Semin Interv Radiol, vol.30, pp.169-175, 2013.
Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study), Lancet Oncol, vol.9, pp.621-628, 2008. ,
Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients, Radiology, vol.247, pp.871-879, 2008. ,
Ablation therapy of non-colorectal cancer lung metastases: retrospective analysis of tumour response post-laser-induced interstitial thermotherapy (LITT), radiofrequency ablation (RFA) and microwave ablation (MWA), Int J Hyperth, vol.33, pp.820-829, 2017. ,
CT fluoroscopy-guided percutaneous fiducial marker placement for CyberKnife stereotactic radiosurgery: technical results and complications in 222 consecutive procedures, J Vasc Interv Radiol, vol.25, pp.760-768, 2014. ,
Complication rates of CT-guided transthoracic lung biopsy: meta-analysis, Eur Radiol, vol.27, pp.138-148, 2017. ,
Risk factors for hemoptysis complicating 17-18 gauge CT-guided transthoracic needle core biopsy: multivariate analysis of 249 procedures, Diagn Interv Radiol, vol.23, pp.347-353, 2017. ,
Two cases of needletract seeding after percutaneous radiofrequency ablation for lung cancer, J Vasc Interv Radiol, vol.20, pp.415-418, 2009. ,
Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, Chest, vol.143, pp.278-313, 2013. ,
THE SURGICAL TREATMENT OF METASTATIC TUMORS IN THE LUNGS, J Thorac Cardiovasc Surg, vol.49, pp.357-363, 1965. ,
Preoperative Evaluation and Indications for Pulmonary Metastasectomy, Thorac Surg Clin, vol.26, pp.7-12, 2016. ,
Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases, J Thorac Cardiovasc Surg, vol.113, pp.37-49, 1997. ,
Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis, Ann Surg Oncol, vol.20, pp.572-579, 2013. ,
Radiofrequency ablation as an adjunct to systemic chemotherapy for colorectal pulmonary metastases, Cancer, vol.116, pp.2106-2114, 2010. ,
Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients, Radiology, vol.243, pp.268-275, 2007. ,
Microwave ablation therapy: clinical utility in treatment of pulmonary metastases, Radiology, vol.261, pp.643-651, 2011. ,
CT-guided percutaneous microwave ablation of pulmonary malignancies: Results in 69 cases, World J Surg Oncol, vol.10, p.80, 2012. ,
Thermal Ablation of Lung Tumors: Focus on Microwave Ablation, ROFO Fortschr Geb Rontgenstr Nuklearmed, vol.189, pp.828-843, 2017. ,
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials, Lancet Oncol, vol.16, pp.630-637, 2015. ,
Survival and prognostic factors in 321 patients treated with stereotactic body radiotherapy for oligo-metastases, Radiother Oncol J, vol.114, pp.155-160, 2015. ,
,
, Stereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-Analysis, Technol Cancer Res Treat, 2018.
Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer, Int J Radiat Oncol Biol Phys, vol.64, pp.473-482, 2006. ,
Reirradiation for locoregionally recurrent non-small cell lung cancer, J Thorac Dis, vol.10, pp.2522-2536, 2018. ,
Detection of local tumor progression by (18)F-FDG PET/CT following lung radiofrequency ablation: PET versus CT, Clin Nucl Med, vol.38, pp.166-170, 2013. ,
Role of PET/Computed Tomography in Radiofrequency Ablation for Malignant Pulmonary Tumors, PET Clin, vol.11, pp.47-55, 2016. ,
A phase II study of radiofrequency ablation therapy for thoracic malignancies with evaluation by FDG-PET, J Cancer Res Clin Oncol, vol.140, pp.1957-1963, 2014. ,
Incomplete radiofrequency ablation accelerates proliferation and angiogenesis of residual lung carcinomas via HSP70/HIF-1?, Oncol Rep, vol.36, pp.659-368, 2016. ,
, , 2018.
,
ABSTRACT : Background: The purpose of this study was to evaluate the safety and long-term efficacy of radiofrequency ablation in lung tumors using small 17-gauge needles. Materials and methods: All patients with lung tumors treated using radiofrequency ablation performed with 17-gauge needles between, Safety and long term efficacy of radiofrequency ablation for lung tumors, 2005. ,
Results: Forty-two consecutive patients with 57 lung tumors including 5 patients with lung carcinoma, 19 patients with colorectal carcinoma metastasis and 18 patients with metastasis from other origin met the inclusion criteria. Median tumor size was 24.4 mm (range: 11-60 mm). Three patients (5.8%) presented with major complications including hemoptysis treated conservatively (n=2) and pneumothorax requiring chest tube placement (n=1), patients underwent clinical and imaging follow-up at regular intervals up to 10 years ,
, lung-free and progression free survival were 46% and 41%, respectively. Median overall survival was 29.8 months (1.8 -154.4) and median overall survival without progression were 25.6 months. Overall survival rates at 1-, 2-, 3-, 4-and 5-years were 93%, 71%, 58%, 39% and 31%, respectively. Conclusion: Radiofrequency ablation using small 17-gauge needles is a valuable treatment option of small size lung tumors
, les patients atteints de tumeurs pulmonaires traités par RF ont été inclus dans une étude prospective mono centrique. Toutes les RF étaient réalisées sous anesthésie générale. Les patients bénéficiaient d'un suivi clinique et radiologique à 3, 6, 12, 15 mois, puis tous les 6 mois jusque dix ans après la RF. Résultats: Cinquante-six RF ont été réalisées sur 42 patients avec 57 tumeurs. Cinq patients étaient porteurs de primitif pulmonaire, 19 patients de métastases de cancer colo-rectal et 18 patients de métastases issues d'autre primitif. La taille médiane des tumeurs était de 24.4mm (11-60mm). Chez les patients présentant une récidive locale la taille de la tumeur était de 27.0 ± 7.5 mm contre 21.5 ± 5.1 mm chez les patients sans récidive locale. Le suivi moyen, Introduction: L'objectif de cette étude était d'évaluer l'efficacité et le taux de complication de la radiofréquence pulmonaire (RF) dans le traitement des lésions primitives et secondaires. Matériels et méthodes: Entre juin 2005 et octobre, 2008.
, La médiane de survie globale était de 29.8 mois (1.8 -154.4). Les taux de survie globale étaient respectivement de 93%, 71%, 58%, 39% et 31% à 1, 2, 3, 4 et 5 ans après RF. Le taux de complications majeures (pneumothorax, hémoptysie) était de 5,8%. Conclusion: La RF des lésions néoplasiques pulmonaires avec une aiguille 17G apparait dans notre étude comme un traitement efficace avec un faible taux de complications majeures
,